GlassScriptPhysician profile
James Benjamin Pratt
NPI 1649720517
$3,701.03
in general payments reported to CMS, 2019-2025
20 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,051 · 2022: $1,472 · 2023: $405 · 2024: $246 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.26 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $655.85 | 2021-2025 | |
| Janssen Biotech, INC. | $554.62 | 2021-2025 | Tremfya, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $362.17 | 2022-2024 | |
| Amgen INC. | $332.76 | 2021-2025 | Otezla, Otezla |
| Lilly USA, LLC | $293.64 | 2021-2025 | Taltz, Olumiant |
| Pfizer INC. | $261.44 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $211.14 | 2021-2022 | |
| Ucb, INC. | $203.38 | 2021-2025 | Bimzelx |
| Genzyme Corporation | $170.07 | 2021-2025 | |
| Incyte Corporation | $164.98 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $100.81 | 2021-2023 | Dupixent |
| Leo Pharma INC. | $74.01 | 2022-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $73.07 | 2021-2022 | |
| Genentech USA, INC. | $71.60 | 2022 | |
| Galderma Laboratories, L.P. | $59.60 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.75 | 2021-2022 | |
| Dermavant Sciences, INC. | $22.87 | 2023 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $13.64 | 2023 | Sotyktu |
| Organon LLC | $8.76 | 2025 | |
| Biowound Solutions, INC. | $7.87 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.